Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Tamgiblimab

(Synonyms: IBI-939, IBI939, IBI 939) Copy Product Info
🥰Excellent

Synonyms: IBI-939, IBI939, IBI 939

Catalog No. T81049 Copy Product Info
Purity: 95%
🥰Excellent
Tamgiblimab (IBI939) is a fully humanized monoclonal antibody targeting TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains), applicable for cancer research.
Tamgiblimab
Cas No. 2411914-36-6
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$123-In Stock
5 mg$297-In Stock
10 mg$455-In Stock
25 mg$733-In Stock
50 mg$987-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:95%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Product Introduction

Bioactivity
Description
Tamgiblimab (IBI939) is a fully humanized monoclonal antibody targeting TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains), applicable for cancer research.
SynonymsIBI-939, IBI939, IBI 939
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetTIGIT
Chemical Properties
Cas No.2411914-36-6
Antibody Information
IsotypeIgG4SP-FLAA-noK
Storage & Solubility Information
StorageStore at low temperature Store at -20°C Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion
Related Tags: